Cargando…
Expression of Programmed Death-Ligand 1 and Programmed Death-1 in Patients with Extramammary Paget's Disease
BACKGROUND: Extramammary Paget's disease (EMPD) is a rare skin cancer and sometimes has fatal prognosis. For progressive cases, therapeutic options are limited. In recent years, treatment with an anti-programmed death-1 (PD-1) antibody has improved the prognosis of various malignancies. In addi...
Autores principales: | Goto, Hiroyuki, Sugita, Kazunari, Yamamoto, Osamu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8208280/ https://www.ncbi.nlm.nih.gov/pubmed/34188273 http://dx.doi.org/10.4103/ijd.IJD_341_18 |
Ejemplares similares
-
Expression of Programmed Death-Ligand 1 in Cutaneous Squamous Cell Carcinoma Arising in Sun-Exposed and Nonsun-Exposed Skin
por: Goto, Hiroyuki, et al.
Publicado: (2020) -
Use of an Anal Retractor Device for Excision in Patients with Perianal Extramammary Paget's Disease
por: Yoshida, Yuichi, et al.
Publicado: (2018) -
High Expression of Lactate Dehydrogenase A is a Potential Promoter of Malignant Behaviour in Extramammary Paget’s Disease
por: OGAWA, Kohei, et al.
Publicado: (2021) -
Extramammary Paget’s disease
por: Vasquez, Andres, et al.
Publicado: (2016) -
Hypercalcemia Associated with Extramammary Paget's Disease
por: Sato, Tetsuko, et al.
Publicado: (2020)